Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$0.85 - $1.43 $1.56 Million - $2.62 Million
-1,831,300 Reduced 99.0%
18,488 $17,000
Q2 2023

Aug 02, 2023

BUY
$1.12 - $1.49 $40,789 - $54,264
36,419 Added 2.01%
1,849,788 $2.2 Million
Q1 2023

Apr 19, 2023

BUY
$1.19 - $2.19 $2.16 Million - $3.97 Million
1,813,369 New
1,813,369 $2.72 Million
Q4 2021

Jan 31, 2022

SELL
$3.24 - $5.18 $2.47 Million - $3.95 Million
-761,816 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$3.94 - $5.84 $132,368 - $196,200
33,596 Added 4.61%
761,816 $3.89 Million
Q2 2021

Aug 10, 2021

BUY
$4.26 - $6.5 $286,335 - $436,897
67,215 Added 10.17%
728,220 $3.19 Million
Q1 2021

May 04, 2021

BUY
$5.03 - $8.8 $185,471 - $324,482
36,873 Added 5.91%
661,005 $4.11 Million
Q4 2020

Feb 03, 2021

BUY
$4.04 - $5.31 $89,768 - $117,988
22,220 Added 3.69%
624,132 $3.05 Million
Q3 2020

Oct 30, 2020

BUY
$3.64 - $7.76 $64,300 - $137,080
17,665 Added 3.02%
601,912 $2.53 Million
Q2 2020

Aug 11, 2020

BUY
$4.78 - $8.26 $2.79 Million - $4.83 Million
584,247 New
584,247 $4.04 Million
Q1 2020

May 01, 2020

SELL
$4.0 - $21.53 $1.38 Million - $7.44 Million
-345,479 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$13.94 - $24.12 $4.82 Million - $8.33 Million
345,479 New
345,479 $7.41 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.